Affinity profiles of novel δ-receptor selective benzofuran derivatives of non-peptide opioids

Neurochemical Research

Volumn 23, Issue 9, 1998, Pages 1211-1216

  Spetea, Mariana ^a   Nevin, Simon T ^a,d   Hosztafi, Sándor ^b   Rónai, András Z ^c   Tóth, Geza ^a   Borsodi, Anna ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b Alkaloida Chemical Company Ltd   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

selectivity; Binding; Naloxone benzofuran; Opioid receptor; Oxycodone benzofuran; Oxymorphone benzofuran

Indexed keywords

BENZOFURAN DERIVATIVE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTREXONE; NALTRIBEN; NALTRINDOLE; OXYCODONE; OXYMORPHONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; BENZENEACETAMIDES; BENZOFURANS; BINDING, COMPETITIVE; BRAIN; CELL MEMBRANE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; NALOXONE; NALTREXONE; OLIGOPEPTIDES; OXYCODONE; OXYMORPHONE; PYRROLIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; TRITIUM;

ANIMALIA;

EID: 0031927607     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020738304036     Document Type: Article

References (32)

1. Borsodi, A., and Tóth, G. 1995. Characterization of opioid receptor types and subtypes with new ligands. Ann. NY Acad. Sci. 757: 339-352.
2. Schiller, P. W. 1991. Development of receptor-specific opioid peptide analogues. Pages 301-340, in Ellis, G. P., and West, G. B. (eds.), Progress in Medicinal Chemistry, Vol. 28, Elsevier Science Publishers, Amsterdam.
3. Takemori, A. E., and Portoghese, P. S. 1992. Selective naltrexonederived opioid receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:239-269.
4. Gold, M. S., Dackis, C. A., Pottash, A. L., Sternbach, H. H., and Anitto, W. J. 1982. Naltrexone, opiate addiction and endorphins. Med. Res. Rev. 2:211-246.
5. Zimmerman, D. M., and Leander, J. D. 1990. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J. Med. Chem 33:895-902.
6. Schwyzer, R. 1977. ACTH: a short introductory review. Ann. NY Acad. Sci. 247:3-36.
7. Portoghese, P. S. 1989. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 10:230-235.
8. Portoghese, P. S., Sultana, M., Nagase, N., and Takemori, A. E. 1988. Application of the message-address concept in the design of highly potent and selective non-peptide δ opioid receptor antagonist. J. Med. Chem. 31:281-282.
9. Portoghese, P. S., Sultana, M., and Takemori, A. E. 1990. Design of peptidomimetic δ opioid receptor antagonists using the message-address concept. J. Med. Chem. 33:1714-1720.
10. Portoghese, P. S., Nagase, H., MaloneyHuss, K. E., Lin, A.-E., and Takemori, A. E. 1991. Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole. J. Med. Chem. 34:1715-1720.
11. 3H]naloxone binding sites by C-6 derivatives of morphinane-6-ones. Life Sci. 48:439-451.
12. Fürst, S., Fiederman, T., Hosztafi, S., and Borsodi, A. 1994. Different μ opioid receptor subtypes may mediate C-6 substitutes oxycodone derivatives induced antinociceptive, gastrointestinal and respiratory actions. Regul. Pept. Suppl 1:S105-S106.
13. 3H]naloxone of high specific activity. J. Label. Com. Radiopharm. 19:1021-1030.
14. 3H]naltrindole binding to delta opioid receptors in rat brain. Life Sci. 50:PL119-PL124.
15. 3H]naltrindole in rat brain membranes. Br. J. Pharmacol. 109:17.
16. 5,6deltorphin II. Neuropeptides 26:261-265.
17. Nevin, S. T., Tóth, G., Weltrowska, G., Schiller, P. W., and Borsodi, A. 1995. Synthesis and binding characteristics of tritiated TIPP[Ψ], a highly specific and stable delta opioid antagonist. Life Sci. 56:PL225-PL230.
18. Simon, J., Benyhe, S., Abutidze, K., Borsodi, A., Szücs, M., and Wollemann, M. 1986. Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS. J. Neurochem. 46:695-701.
19. 5]enkephalin. Life Sci. 45:1001-1008.
20. Bradford, M. M. 1986. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 72:248-254.
21. Munson, P. J., and Rodbard, D. 1980. LIGAND: a versatile computerized approach for characterization of ligand binding studies. Anal. Biochem. 107:220-227.
22. 3H]-Tyr-D-Ala-Gly-(Me)Phechlormethyl ketone. Life Sci. 48:1757-1762.
23. 61-64 possessing selective agonist activity at μ-opiate receptors. Eur. J. Pharmacol. 70:531-540.
24. 3H]U69-593, a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109:281-284.
25. Pert, C. B., and Snyder, S. H. 1973. Properties of opiate-receptor binding in rat brain. Proc. Natl. Acad. Sci. 70:2243-2247.
26. Oguri, K., Yamada-Mori, I., Shigezane, J., Hirano, T., and Yoshimura, H. 1987. Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugation at the 6-position. Life Sci. 41:1457-1467.
27. Chen, Z. R., Irvine, R. J., Somogyi, A. A., and Bochner, F. 1991. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci. 48:2165-2171.
28. Mignat, C., Wille, U., and Ziegler, A. 1995. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 56:793-799.
29. Pasternak, G. W., Bodnar, R. J., Clark, J. A., and Inturrisi, C. E. 1987. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41: 2845-2849.
30. Rónai, A. Z., Gyires, K., Schmidhammer, H., Hosztafi, S., Borsodi, A., Spetea, M., Friedmann, M., Riba, P., and Fürst, Zs. 1997. In vitro and in vivo pharmacology of novel, naltrindole-related compounds. Med. Sci. Monit. 3:1-5.
31. Kosterlitz, H. W., and Paterson, S. J. 1980. Characterization of opioid receptors in nervous tissue. Proc. R. Soc. London Ser B. 210:113-122.
32. Pert, C. B., and Snyder, S. 1974. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10:808-879.